Differential Diagnosis and the Indomethacin Test
At a Glance
Paroxysmal hemicrania is distinguished from similar one-sided headaches by short, frequent attacks and complete relief between them. A supervised indomethacin trial should stop the attacks completely; partial relief usually prompts reconsideration of the diagnosis or evaluation for another cause.
When you have severe, one-sided head pain, getting the right diagnosis can be difficult because several conditions look very similar. Doctors group these together as Trigeminal Autonomic Cephalalgias (TACs) [1]. To tell them apart, your medical team looks at two things: the “stopwatch” (how long the pain lasts) and the “Indo-test” (how the pain reacts to a specific medication) [2][3].
The “Stopwatch” Test: Differentiating TACs
The most important clue in diagnosing Paroxysmal Hemicrania (PH) is the timing and frequency of the attacks. PH lives in a “middle ground” between other types of headaches:
- PH vs. Cluster Headache: Cluster headaches are often called the “big brother” of PH. However, Cluster Headache attacks are much longer—usually lasting between 15 and 180 minutes—and happen less frequently (up to 8 times a day) [2][4]. PH attacks are shorter (2 to 30 minutes) and happen much more often [1].
- PH vs. SUNCT/SUNA: These conditions involve incredibly brief “stabs” of pain that last only seconds to a few minutes [5][6]. They can happen hundreds of times a day and are often triggered by touching the face or washing your hair, which is less common in PH [5].
- PH vs. Hemicrania Continua: While both respond to the same medication, Hemicrania Continua (HC) involves a continuous, 24/7 background ache that never goes away, even when the sharp “spikes” of pain aren’t happening [7][8]. In PH, there is typically a period of total, 100% relief between attacks [1].
The Indomethacin Test (The “Indo-Test”)
The “gold standard” for confirming a PH diagnosis is a diagnostic trial of a medication called indomethacin [1][3]. It is a potent NSAID (non-steroidal anti-inflammatory drug), and while its precise mechanism in PH remains uncertain, its distinct clinical response is diagnostically useful [9].
How the Test Works
Your doctor will likely prescribe a specific “trial” dose. For example, some specialists might start an adult trial at 25 mg taken three times a day [10]. If there is no response, the dose may be increased gradually—sometimes up to 75 mg or even 150 mg per day to ensure the test is thorough [11][12]. These are strictly clinician-directed examples; never start, increase, or repeat a trial without a prescriber.
What a “Complete Response” Means
In the world of PH, “complete” means absolute [1].
- A Positive Result: The headache attacks vanish entirely, sometimes within 24 to 48 hours of reaching the correct dose, while others respond later during a supervised titration [10][13].
- A Negative Result: If the pain does not stop completely at a therapeutic dose, the diagnosis of PH is usually reconsidered, though a negative result can also reflect inadequate dose, poor absorption, or intolerance [1].
Why a “Partial Response” Matters
It is a common misconception that if a headache “gets better” with indomethacin, it must be PH. However, many types of headaches (including some migraines) might feel a little better after taking a strong anti-inflammatory [12].
For a formal diagnosis of Paroxysmal Hemicrania, the response must be absolute [1][14]. If your attacks become less frequent or less intense, but do not stop entirely, your doctor will likely reconsider your diagnosis and may investigate other causes, such as Cluster Headache or a “secondary” headache caused by another underlying issue [1][15]. Because high-dose indomethacin can be hard on the stomach and kidneys, doctors want to be certain of the diagnosis before committing to long-term treatment [16][17].
Common questions in this guide
How is paroxysmal hemicrania different from cluster headache?
What does a complete response to indomethacin mean?
Does partial relief from indomethacin confirm paroxysmal hemicrania?
How quickly should indomethacin work during a diagnostic trial?
What should I know about indomethacin if I have stomach ulcers or acid reflux?
How can doctors distinguish paroxysmal hemicrania from hemicrania continua?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Paroxysmal hemicrania.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.If my pain only gets 50% better on indomethacin, what does that mean for my diagnosis?
- 2.What is the specific dosage schedule you want me to follow for the 'Indo-test'?
- 3.How long should I wait for a response before we decide the test was unsuccessful?
- 4.If I have a history of stomach ulcers or acid reflux, how can we safely perform this diagnostic trial?
- 5.Is it possible for me to have both PH and another type of headache at the same time?
References
References (17)
- 1
Paroxysmal Hemicrania: An Update.
Paliwal VK, Uniyal R
Neurology India 2021; (69(Supplement)):S135-S143 doi:10.4103/0028-3886.315982.
PMID: 34003159 - 2
Trigeminal Autonomic Cephalalgias in Children and Adolescents: Cluster Headache and Related Conditions.
Mack KJ, Goadsby P
Seminars in pediatric neurology 2016; (23(1)):23-6.
PMID: 27017018 - 3
Cluster Headache and Other Trigeminal Autonomic Cephalalgias.
Burish M
Continuum (Minneapolis, Minn.) 2018; (24(4, Headache)):1137-1156 doi:10.1212/CON.0000000000000625.
PMID: 30074553 - 4
Managing cluster headache.
Wei DY, Khalil M, Goadsby PJ
Practical neurology 2019; (19(6)):521-528 doi:10.1136/practneurol-2018-002124.
PMID: 31278205 - 5
SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update.
Kang MK, Cho SJ
Cephalalgia : an international journal of headache 2024; (44(2)):3331024241232256 doi:10.1177/03331024241232256.
PMID: 38415675 - 6
SUNCT and SUNA: An Update.
Duggal AK, Chowdhury D
Neurology India 2021; (69(Supplement)):S144-S159 doi:10.4103/0028-3886.315990.
PMID: 34003160 - 7
Overview of Trigeminal Autonomic Cephalalgias: Nosologic Evolution, Diagnosis, and Management.
Wei DY, Yuan Ong JJ, Goadsby PJ
Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S39-S44 doi:10.4103/aian.AIAN_348_17.
PMID: 29720817 - 8
Hemicrania continua: clinical review, diagnosis and management.
Prakash S, Patel P
Journal of pain research 2017; (10()):1493-1509 doi:10.2147/JPR.S128472.
PMID: 28721092 - 9
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment.
Bahra A
Cephalalgia : an international journal of headache 2023; (43(11)):3331024231214239 doi:10.1177/03331024231214239.
PMID: 37950675 - 10
Menstruation-triggered paroxysmal hemicrania.
Patel S, Shah H, Prakash S
BMJ case reports 2026; (19(8)) doi:10.1136/bcr-2026-274651.
PMID: 42618320 - 11
Paroxysmal hemicrania: A diagnostic challenge presenting as orofacial pain: A case series.
Al-Taee A, Botros J, Groenke BR, Nixdorf DR
Cranio : the journal of craniomandibular practice 2026; (44(4)):721-728 doi:10.1080/08869634.2025.2610489.
PMID: 41456204 - 12
Indomethacin Responsive Headaches: Exhaustive Systematic Review with Pooled Analysis and Critical Appraisal of 81 Published Clinical Studies.
Bordini EC, Bordini CA, Woldeamanuel YW, Rapoport AM
Headache 2016; (56(2)):422-35 doi:10.1111/head.12771.
PMID: 26853085 - 13
Case Report: Shortest Course of Pediatric Paroxysmal Hemicrania.
Ishii R, Fukazawa R, Takezawa H, Fujii A
Headache 2019; (59(7)):1084-1087 doi:10.1111/head.13580.
PMID: 31264201 - 14
Paroxysmal Hemicrania.
Osman C, Bahra A
Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S16-S22 doi:10.4103/aian.AIAN_317_17.
PMID: 29720814 - 15
Indomethacin-Responsive Headache Disorders.
Goadsby PJ
Continuum (Minneapolis, Minn.) 2024; (30(2)):488-497 doi:10.1212/CON.0000000000001409.
PMID: 38568495 - 16
The spectrum of indomethacin-responsive headaches in children and adolescents.
Myers KA, Barmherzig R, Raj NR, et al.
Cephalalgia : an international journal of headache 2022; (42(8)):793-797 doi:10.1177/03331024221076483.
PMID: 35302385 - 17
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?
Osiowski A, Stolarz K, Taterra D
Current opinion in neurology 2025; (38(3)):254-261 doi:10.1097/WCO.0000000000001347.
PMID: 39911098
This page explains how clinicians distinguish paroxysmal hemicrania from similar headaches and use an indomethacin trial for informational purposes only. It does not constitute medical advice; follow dosing and safety instructions from your prescriber.